Login
$KYMR
$125.10 -$2.47 (1.94%) Live

Company Executives

Officer Age In this role 2025 pay Source
Nello Mainolfi Also a director
Chief Executive Officer
Title from the Form 4 dated Oct 1, 2026
47 Not stated $8,545,609
Bruce Jacobs
Chief Financial Officer
56 Since 2019
7 years
$2,903,236
Noah Goodman
Chief Business Officer
39 Since 2025
1 year
$3,172,068
Brian Adams
Chief Legal Officer and Corporate Secretary
52 Not stated $6,071,041
Terence Rooney
Chief Medical Officer
Title from the Form 3 dated Jul 27, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
5.7 years
from year joined
CEO also chairs the board
No
Bruce Booth
Director Age On board Independent Committees Other public boards Pay Source
Bruce Booth
51 2015
11 years
Independent None stated Sionna Therapeutics, Inc. Not stated
Nello Mainolfi
47 2019
7 years
Not independent None stated None stated Paid as CEO
Felix J. Baker
57 2024
2 years
Independent
Compensation Committee
Bicycle Therapeutics PLC, Kodiak Sciences, Inc., Kiniksa Pharmaceuticals International, plc Not stated
John Maraganore
63 2022
4 years
Independent
Compensation Committee
Beam Therapeutics Inc., Rapport Therapeutics, Inc., Takeda Pharmaceuticals Not stated
Elena Ridloff
46 2021
5 years
Independent None stated None stated Not stated
Pamela Esposito
52 2020
6 years
Independent None stated Sapience Therapeutics, Inc., Accent Therapeutics, Inc. Not stated
Gorjan Hrustanovic
37 2020
6 years
Independent
Nominating and Corporate Governance Committee
Olema Pharmaceuticals, Inc. Not stated
Victor Sandor
59 2022
4 years
Independent None stated Prelude Therapeutics Incorporated, ADCT Therapeutics SA Not stated
Jeffrey Albers
54 2020
6 years
Independent
Audit Committee
Spyre Therapeutics Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support